Tag: Philips

Philips and BioIntelliSense form strategic collaboration to enhance remote patient monitoring for at-risk patients from the hospital into the home

July 9, 2020 Philips integrates the BioIntelliSense FDA-cleared BioSticker™ sensor as part of its remote patient monitoring solutions for patients outside the hospital Multi-parameter sensors aid monitoring across multiple chronic conditions with medical-grade vital signs for physicians to remotely track core symptoms, including COVID-19   Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, […]

Philips expands its remote clinical collaboration offering based on the Reacts platform

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is expanding its remote clinical collaboration and virtual training offerings across its portfolio, building on the IIT * (Innovative Imaging Technologies) Reacts collaborative platform. Leveraging innovative technologies, such as augmented reality, for remote virtual guidance, […]

New data reconfirms long-term safety profile of the Philips Stellarex low-dose Drug-Coated Balloon

June 26, 2020 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the four-year results from the ILLUMENATE European Randomized Controlled Trial (EU RCT). The Stellarex DCB cohort demonstrated similar all-cause mortality compared with the control arm through four years. This analysis included […]

Philips and Leeds Teaching Hospitals NHS Trust to set new standards for specialist integrated cardiac care

June 25, 2020 Seven-year agreement puts patients at heart of service design to support increased excellence across specialist care, research and local care provision Amsterdam, the Netherlands and Guildford, UK – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Leeds Teaching Hospitals NHS Trust today announced a […]

Philips receives FDA premarket approval for its HeartStart FR3 and HeartStart FRx automated external defibrillators

Amsterdam, the Netherlands and Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for the company’s HeartStart FR3 [1] and HeartStart FRx [2] […]

Philips receives FDA clearance for the use of its ultrasound portfolio to manage COVID-19-related lung and cardiac complications

May 13, 2020 Philips’ ultrasound portfolio, including Lumify with Reacts handheld tele-ultrasound solution, provides valuable diagnostic insight for front-line care providers   Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration […]

Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images

Randomized controlled trial with up to 3,000 participants at 75 sites to compare outcomes between physiological guidance by iFR data co-registered on the angiogram (interventional X-ray image) versus the standard of care use of an angiogram alone Percutaneous coronary intervention (PCI) is one of the main treatment options to open […]

Zebra Medical Vision’s Solutions Now Available on Philips IntelliSpace AI Workflow Suite, Enabling More AI Capabilities for Radiologists

Zebra-Med’s AI1™ “all-in-one” bundle offering will now be available on Philips’ comprehensive AI platform to empower radiology workflow SHEFAYIM, Israel–(BUSINESS WIRE)–Zebra Medical Vision (https://www.zebra-med.com), the deep learning medical imaging analytics company, announces today that its AI1™ “all-in-one” product bundle will also be available to Philips’ customers through Philips (https://www.philips.com/global) AI Workflow Suite [1], […]